Morpholin-4-ylacetic acid hydrochloride, 97.0%, 10g

(S)-tert-Butyl 2-(bromomethyl)azetidine-1-carboxylate, 97%, 500mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 500 ml, 90 mm, 1 Piece

ATACIGUAT, 95%, 25mg

3-N-Boc-Amino-azetidine, 90.0%, 10g

2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-oic acid, 95.0%, 250mg

TERT-BUTYL 4-(((6-AMINO-5-CHLOROPYRIMIDIN-4-YL)AMINO)METHYL)-3-HYDROXYPIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

Trifluoroacetaldehyde methyl hemiacetal, 90.0%, 5g

4-Bromo-o-xylene, 99.0%, 5g

2-Chloro-3-nitroimidazo[1,2-a]pyridine, 95%, 1g

5-Bromo-2-ethoxypyridine, 98.0%, 1kg

Ambroxol Hydrochloride, 97.0%, 1g

N,N-Diisopropylethylamine (DIPEA), 250mL, >=99.5%, for peptide synthesis, glass packaging